In the United States have successfully completed the first clinical trials of an experimental vaccine against the disease caused by the Ebola virus. This was announced by Director National Institute of Allergy and Infectious Diseases Anthony Fauci, under whose leadership the group of American specialists continues to search for drugs against Ebola virus.
The researchers tested the vaccine on 20 volunteers and received positive results . In particular, under the influence of the drug the immune system of each of them begins to produce antibodies against viruses Ebola. Wherein any harmful side effects, except for a brief increase in temperature of the two patients was observed. Fauci called it “a promising factor,” and stressed that now science has become a “one step closer” to the development of a vaccine against the deadly disease. American experts said that they would continue their studies.
On Tuesday, December 2, US President Barack Obama plans to visit the National Institute of Allergy and Infectious Diseases to thank Fauci and his colleagues for their efforts in the fight against Ebola virus. Head of Administration intends to urge Congress to approve the selection in 2015 of additional budget funds for this purpose.
Before reported , that, according to the World Health Organization, the death toll from the Ebola virus reached 5689 people, with 15 935 identified cases of infection.
No comments:
Post a Comment